Tacrolimus and Alpha 1 foetoprotein increased - a phase IV clinical study of FDA data

Summary:

Alpha 1 foetoprotein increased is reported as a side effect among people who take Tacrolimus (tacrolimus), especially for people who are male, 50-59 old, have been taking the drug for 2 - 5 years also take Myfortic, and have Hepatitis c.

The phase IV clinical study analyzes which people have Alpha 1 foetoprotein increased when taking Tacrolimus. It is created by eHealthMe based on reports of 115,828 people who have side effects when taking Tacrolimus from the FDA, and is updated regularly.

What is Tacrolimus?

Tacrolimus has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 116,160 Tacrolimus users. Check the latest studies of Tacrolimus.

What is Alpha 1 foetoprotein increased?

Alpha 1 foetoprotein increased is found to be associated with 121 drugs and 205 conditions by eHealthMe. Check the latest studies of Alpha 1 foetoprotein increased.

On Jul, 14, 2026

115,828 people reported to have side effects when taking Tacrolimus.
Among them, 12 people (0.01%) have Alpha 1 foetoprotein increased.

Could Tacrolimus cause Alpha 1 foetoprotein increased?

Among these 12 people:

How long have people been on Tacrolimus when they have Alpha 1 foetoprotein increased? *

What is the gender of people who have Alpha 1 foetoprotein increased when taking Tacrolimus? *

female: 8.33 %
male: 91.67 %

What is the age of people who have Alpha 1 foetoprotein increased when taking Tacrolimus? *

What are other drugs people take besides Tacrolimus? *

What are other side effects people have besides Alpha 1 foetoprotein increased? *

Immunosuppressant Drug Level Increased: 4 people, 33.33%
Hepatitis C: 3 people, 25.00%
Hallucination, Visual (seeing things that aren't there): 2 people, 16.67%
Confusion Postoperative: 2 people, 16.67%
Drug Ineffective: 2 people, 16.67%
General Physical Health Deterioration (weak health status): 2 people, 16.67%
Hepatic Fibrosis (scarring process that represents the liver's response to injury): 2 people, 16.67%
Hepatic Neoplasm Malignant (liver cancer): 2 people, 16.67%
Hepatocellular Carcinoma (liver cancer): 2 people, 16.67%
Hyperkalemia (damage to or disease of the kidney): 2 people, 16.67%

What are the existing conditions these people have? *

Hepatitis C: 5 people, 41.67%
Tyrosinaemia (tyrosine metabolism resulting in liver and kidney disturbances and mental retardation): 2 people, 16.67%
Diabetes: 2 people, 16.67%
Hepatoblastoma (liver cancer): 1 person, 8.33%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Tacrolimus and have Alpha 1 foetoprotein increased?

- Check whether Alpha 1 foetoprotein increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tacrolimus:

Tacrolimus (116,160 reports)

Browse all side effects of Tacrolimus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Alpha 1 foetoprotein increased:

Alpha 1 foetoprotein increased (121 drugs)

Browse all the conditions that are associated with Alpha 1 foetoprotein increased:

Alpha 1 foetoprotein increased (205 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tacrolimus (the active ingredients of Tacrolimus) and Tacrolimus (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.